A lot of people remember the first time they saw eye floaters. It usually happens at random. You could be looking at the sky, ...

Ocular Therapeutix Inc. (NASDAQ:OCUL) is one of the best low priced biotech stocks to invest in. Ocular Therapeutix Inc.

This case report describes a woman in her 60s diagnosed with primary vitreoretinal lymphoma (PVRL) with leptomeningeal ...

New SOL-1 post-hoc analyses presented at VBS reinforce AXPAXLI's unmatched durability in wet AMD with sustained disease control AXPAXLI demonstrated robust CSFT control with a median time of 39 weeks ...

New SOL-1 post-hoc analyses presented at VBS reinforce AXPAXLI's unmatched durability in wet AMD with sustained disease control AXPAXLI demonstrated robust CSFT control with a median time of 39 weeks ...

Detailed price information for Ocular Therapeut (OCUL-Q) from The Globe and Mail including charting and trades.

FDA approves Eylea HD for extended 20-week dosing in patients with wet age-related macular degeneration and diabetic macular edema.

The VFFQ-23 may be superior to the VFQ-25 for identifying patients who may benefit from surgical intervention for vitreous floaters. For patient’s with vitreous floaters, a questionnaire correlates ...

In primary care settings, new‑onset vitreous floaters strongly predict retinal detachment (RD), a risk that increases with the additional presence of flashes, and increases significantly when both ...

I’m a 73-year-old man who had worn glasses since the age of 12 until a successful laser surgery from 22 years ago, which resulted in near 20/20 vision. My vision has changed little since the surgery.

My eye health has always been very good, if not excellent, but after a recent two-hour airplane flight, I noticed a small “blob” in my right eye. Every time I moved my eye, it moved with my direction ...